CLINICAL_TRIALS
trial_result
· 2018-10-18
Clinical Trial Update: Phase III Study of ASP2151 in Herpes Zoster Patients [Phase 3]
Summary
Phase III study of ASP2151 in herpes zoster has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Maruho Co., Ltd. | Conditions: Herpes Zoster | Phase 3 | Status: COMPLETED | Results posted: 2018-10-18